Activation of mitogen-activated protein kinase cascade and phosphorylation of cytoskeletal proteins after neurone-specific activation of p21ras. II. Cytoskeletal proteins and dendritic morphology

Neuroscience

Volumn 105, Issue 4, 2001, Pages 1041-1054

  Holzer, M ^a   Rodel L ^a   Seeger, G ^a   Gartner U ^a   Narz, F ^b   Janke, C ^a   Heumann, R ^b   Arendt, Th ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Alzheimer's disease; Cytoskeleton; Neurofibrillary degeneration; Protein phosphorylation; Signal transduction; Tau protein

Indexed keywords

12E8 ANTIBODY; AT270 ANTIBODY; CYTOSKELETON PROTEIN; EPITOPE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; PROTEIN P21; SM134 ANTIBODY; SYNAPSIN I; TAU PROTEIN; TUBULIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOREACTIVITY; MOUSE; NERVE FIBER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PYRAMIDAL NERVE CELL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; CYTOSKELETAL PROTEINS; DENDRITES; ENZYME ACTIVATION; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROGLIA; NEURONS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS P21(RAS); RNA, MESSENGER; SUBCELLULAR FRACTIONS; TAU PROTEINS; TISSUE DISTRIBUTION;

EID: 0035934224     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00246-9     Document Type: Article

References (81)

1. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5
2. Modulation of PHF-like tau phosphorylation in cultured neurones and transfected cells
3. Phosphorylation of tau, Aβ-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A
4. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine
5. Tau aggregation into fibrillar polymers: Taupathies
6. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease
7. Ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neurons
8. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads
9. 396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
10. Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation
11. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease
12. Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenes
13. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
14. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
15. Autoregulation of tubulin synthesis in enucleated cells
16. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin
17. Unpolymerized tubulin modulates the level of tubulin mRNAs
18. Stathmin and its phosphoprotein family: General properties, biochemical and functional interaction with tubulin
19. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption
20. Mitogen activated protein (Map) kinase transforms tau-protein into an Alzheimer-like state
21. Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells
22. Association of tau protein with microtubules in living cells
23. Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes
24. Glial fibrillary acidic protein: A review of structure, function, and clinical application
25. Neuronal apoptosis is associated with a decrease in tau mRNA expression
26. Structure of tau protein and assembly into paired helical filaments
27. Postmortem changes in the phosphorylation state of tau-protein in the rat brain
28. Molecular characterization of microtubule-associated proteins-tau and map2
29. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases
30. Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization
31. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: Identification of phosphorylation sites in tau protein
32. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
33. Multiple isoforms of human microtubule-associated protein tau: Sequences and localisation in neurofibrillary tangles of Alzheimer's disease
34. Somatodentritic localisation and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform
35. Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ
36. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry
37. Transgenic activation of ras in neurons promotes hypertrophy and protects from lesion-induced degeneration
38. Molecular architecture and dynamics of the neuronal cytoskeleton
39. Activation of mitogen activated protein kinase cascade (MAPK)-cascade and phosphorylation of cytoskeletal proteins after neuron-specific activation of p21ras. I. MAPK cascade
40. Abnormally phosphorylated tau protein in Alzheimer's disease: Heterogeneity of individual regional distribution and relationship to clinical severity
41. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: Implications for Alzheimer's disease
42. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform
43. Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine threonine kinase Mos
44. Phylogenetic diversity of the expression of the microtubule-associated protein tau: Implications for neurodegenerative disorders
45. Distribution of isoforms of the microtubule-associated protein tau in grey and white matter areas of human brain: A two-dimensional gel electrophoretic analysis
46. Cytoskeletal changes in the brains of mice lacking calcineurin Aa
47. Tau in situ hybridization in normal and Alzheimer brain: Localization in the somatodendritic compartment
48. Stimulation of MAP kinase by v-raf transformation of fibroblasts fails to induce hyperphosphorylation of transfected tau
49. Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation
50. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
51. Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau
52. The purification of tau protein and the occurrence of two phosphorylation states of tau in brain
53. Phosphorylation by cAMP-dependent protein kinase inhibits the degradation of tau by calpain
54. The phosphorylation of tau: A critical stage in neurodevelopment and neurodegenerative processes
55. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells
56. Serine 25 of oncoproteine 18 is a major cytosolic target for the mitogen-activated protein kinase
57. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau
58. Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes
59. Activation of a PP2A-like phosphatase and dephosphorylation of τ protein characterize onset of the execution phase of apoptosis
60. Apoptosis-related protein expression in the hippocampus in Alzheimer's disease
61. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404
62. A simplification of the protein assay method of Lowry et al. which is more generally applicable
63. Retention of autoregulatory control of tubulin in cytoplasts: Demonstration of a cytoplasmic mechanism that regulates the level of tubulin expression
64. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
65. Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogene
66. Ras-signaling pathways: Positive and negative regulation of tau expression in PC12 cells
67. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function
68. Diverse distribution and function of fibrous microtubule associated proteins in the nervous system
69. INK4a
70. 262 in fetal tau, adult tau, and paired helical filament tau
71. Aluminum modifies the properties of Alzheimer's disease PHFτ proteins in vivo and in vitro
72. Tau mutations in familial frontotemporal dementia
73. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein
74. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice
75. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B
76. Glycosylation of microtubule-associated protein tau: An abnormal posttranslational modification in Alzheimer's disease
77. A protein factor essential for microtubule assembly
78. Neuronal microtubules, neurofilaments, and microfilaments
79. Calcineurin inhibition prevents calpain-mediated proteolysis of tau in differentiated PC12 cells
80. Brefeldin A-induced apoptosis is expressed in rat neurons with dephosphorylated tau protein